119 related articles for article (PubMed ID: 3020109)
1. Antiarrhythmic efficacy of propranolol: comparison of low and high serum concentrations.
Duff HJ; Mitchell LB; Wyse DG
J Am Coll Cardiol; 1986 Oct; 8(4):959-65. PubMed ID: 3020109
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic actions of high plasma concentrations of propranolol in human subjects.
Duff HJ; Roden DM; Brorson L; Wood AJ; Dawson AK; Primm RK; Oates JA; Smith RF; Woosley RL
J Am Coll Cardiol; 1983 Dec; 2(6):1134-40. PubMed ID: 6630784
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic effects of epinephrine in humans.
Morady F; Nelson SD; Kou WH; Pratley R; Schmaltz S; De Buitleir M; Halter JB
J Am Coll Cardiol; 1988 Jun; 11(6):1235-44. PubMed ID: 2835408
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic efficacy, clinical electrophysiology, and pharmacokinetics of 3-methoxy-O-desmethyl encainide (MODE) in patients with inducible ventricular tachycardia or fibrillation.
Roden DM; Lee JT; Woosley RL; Echt DS
Circulation; 1989 Nov; 80(5):1247-58. PubMed ID: 2805262
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic, electrocardiographic, electrophysiologic and pharmacokinetic activity of 4'-hydroxypropranolol in dogs.
Muir WW; Sams RA; Schall SF
J Vet Pharmacol Ther; 1996 Aug; 19(4):259-67. PubMed ID: 8866453
[TBL] [Abstract][Full Text] [Related]
6. Effect of some beta adrenergic blocking agents and phenytoin on potentiation of quinidine antiarrhythmic activity in the mouse.
Lawson JW
Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):106-15. PubMed ID: 6149731
[TBL] [Abstract][Full Text] [Related]
7. Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade.
Murray KT; Reilly C; Koshakji RP; Roden DM; Lineberry MD; Wood AJ; Siddoway LA; Barbey JT; Woosley RL
J Clin Invest; 1990 Mar; 85(3):836-42. PubMed ID: 2155929
[TBL] [Abstract][Full Text] [Related]
8. Right ventricular tachycardia: clinical and electrophysiologic characteristics.
Buxton AE; Waxman HL; Marchlinski FE; Simson MB; Cassidy D; Josephson ME
Circulation; 1983 Nov; 68(5):917-27. PubMed ID: 6137291
[TBL] [Abstract][Full Text] [Related]
9. Amiloride. Antiarrhythmic and electrophysiologic actions in patients with inducible sustained ventricular tachycardia.
Duff HJ; Mitchell LB; Kavanagh KM; Manyari DE; Gillis AM; Wyse DG
Circulation; 1989 Jun; 79(6):1257-63. PubMed ID: 2720927
[TBL] [Abstract][Full Text] [Related]
10. Changes in myocardial metabolism and transcardiac electrolytes during simulated ventricular tachycardia: effects of beta-adrenergic blockade.
Peuhkurinen KJ; Huikuri HV; Linnaluoto M; Takkunen JT
Am Heart J; 1994 Jul; 128(1):96-105. PubMed ID: 8017290
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of isoproterenol facilitation of ventricular tachycardia induction during extrastimulus testing in predicting effective chronic therapy with beta-adrenergic blockade.
Olshansky B; Martins JB
Am J Cardiol; 1987 Mar; 59(6):573-7. PubMed ID: 2881479
[TBL] [Abstract][Full Text] [Related]
12. Beta-adrenoceptor blockade: electrophysiology and antiarrhythmic mechanisms.
Sung RJ; Tai DY; Svinarich JT
Am Heart J; 1984 Oct; 108(4 Pt 2):1115-20. PubMed ID: 6148871
[TBL] [Abstract][Full Text] [Related]
13. Plasma propranolol levels in the quaniitative assessment of beta-adrenergic blockade in man.
Coltart DJ; Shand DG
Br Med J; 1970 Sep; 3(5725):731-4. PubMed ID: 4394650
[TBL] [Abstract][Full Text] [Related]
14. Suppression of chronic ventricular arrhythmias with propranolol.
Woosley RL; Kornhauser D; Smith R; Reele S; Higgins SB; Nies AS; Shand DG; Oates JA
Circulation; 1979 Oct; 60(4):819-27. PubMed ID: 476887
[TBL] [Abstract][Full Text] [Related]
15. Electropharmacology of nonsustained ventricular tachycardia: effects of class I antiarrhythmic agents, verapamil and propranolol.
Buxton AE; Waxman HL; Marchlinski FE; Josephson ME
Am J Cardiol; 1984 Mar; 53(6):738-44. PubMed ID: 6702622
[TBL] [Abstract][Full Text] [Related]
16. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
Kuchar DL; Garan H; Ruskin JN
Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
Steinbeck G; Bach P; Haberl R
J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
[TBL] [Abstract][Full Text] [Related]
19. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL
Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
